62 天前 - … COVID-19 in pregnancy. One participant stated that she had rejected the COVID-19 …
of multiple miscarriages attributable to the COVID-19 vaccine with no evidence. Other posts …

63 天前 - … The COVID-19 pandemic has led to a rethinking of clinical trial design to maintain
clinical research activity, with regulatory changes allowing for the wider implementation and …

67 天前 - … was the COVID-19 … to immunotherapy treatment. The quicker updosing protocol
improved patients’ acceptance of treatment and increased the efficiency of our immunotherapy …

68 天前 - … recent advancements in utilizing immunotherapy for the … current research on
immunotherapies (including vaccines) … are focused on immunotherapies against various viruses, …

68 天前 - … The five most commonly reported side effects were COVID-19 infection, upper
respiratory tract infection, headache, swelling of the lymph nodes, and pink eye (conjunctivitis) in …

69 天前 - … that is often used as immunotherapy in combination with … SARS-CoV-2 (COVID-19)
infection in patients treated with … severe-to-critical COVID-19 infection than rituximab (35% …

69 天前 - … as SARS-CoV-1 and COVID-19. This is the first report of … ICI immunotherapy,
especially anti-PD-1/PD-L1. Prognosis is poorer in older patients and those using pembrolizumab, …

69 天前 - … This could be due to gathering restrictions, as was the case during the COVID-19
pandemic, or for lack of shelters in health care facilities in areas of war. Given these …

70 天前 - … infectious diseases such as coronavirus disease 2019 (COVID-19) have become a
familiar … limited to therapeutic drugs or allergen immunotherapy. Therefore, elucidating new …

71 天前 - … and immunotherapy. Several studies conducted in the early stages of the COVID-19
pandemic … This study aimed to investigate the clinical course and prognosis of COVID-19 in …